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Abstract: 
G-Protein Signaling Modulator 3 (GPSM3), a GoLoco family protein that regulates G 
protein coupled receptors (GPCRs), is highly expressed in immune cells, particularly 
monocytes. Single nucleotide polymorphisms (SNPs) at the GPSM3 gene locus that were 
associated with a decreased incidence of autoimmunity in humans have been shown to 
correlate with reduced transcript and protein expression. Furthermore, Gpsm3-/- mice fail to 
develop inflammatory disease in two preclinical mouse models of rheumatoid arthritis, but the 
underlying cellular and molecular mechanisms are currently unknown. Our published and 
preliminary data suggest that Gpsm3 expression levels impact monocyte survival, which could 
explain why Gpsm3-/- mice fail to develop inflammatory arthritis. To directly test the impact of 
Gpsm3 on monocyte survival ex vivo, monocytes were differentiated from the bone marrow of 
wild type and Gpsm3-/- mice and treated with one of four chemokines known to regulate 
monocyte function (Ccl2, Cx3cl1, chemerin, and Cxcl12) under apoptotic stress. Monocyte 
survival versus apoptosis was then measured. Preliminary results suggested that Cx3cl1, 
chemerin and Cxcl12 all protect against apoptosis in wild type monocytes, but fail to protect the 
Gpsm3-/- monocytes. Future directions involve identifying potential leukocyte subpopulations, 
including macrophages, which are also dependent on Gpsm3 for survival. Overall, Gpsm3 is 
critical to the development of monocyte inflammatory responses and could impact future 
development of novel therapeutic targets for the treatment of arthritis in humans.  
 
 
 
 
 
Introduction: 
 Monocytes are myeloid-derived leukocytes that differentiate into macrophages. 
Together, monocytes and macrophages make up one of the innate immune system’s primary 
lines of defense against pathogens; but they are also involved in chronic inflammatory and 
autoimmune diseases[1].  These cells secrete the chemokines interleukin-1β, interleukin-6, 
tumor necrosis factor-α, interleukin-23, and interferon-γ which are involved in the pathogenesis 
of autoimmunity[2].  Furthermore, although monocytes and macrophages are not likely the 
originators of rheumatoid arthritis (RA), they have pro-inflammatory, destructive and remodeling 
capacities which play a substantial role in disease[3]. 
Monocyte and macrophage activation, survival, and chemotaxis can be regulated by G-
protein coupled receptors (GPCRs)[4]. These seven transmembrane receptors are linked to a 
heterotrimeric G-protein composed of a G, G, and G subunit. The G subunit is activated 
through guanine nucleotide exchange; it is inactive when bound to GDP and in an activated 
state when bound to GTP.  The G and G subunits heterodimerize and bind with high affinity to 
G when it’s bound to GDP and, therefore, in its inactive form.  Upon ligand binding, the 
receptor facilitates the release of GDP, after which G binds GTP and undergoes a 
conformational change that causes it to release G[5].  GTP bound G and G independently 
initiate signals. G-Protein Signaling Modulator 3 (GPSM3), also known as G18 or AGS4, is a 
GoLoco family protein that is highly expressed in monocytes. The functional GoLoco motifs of 
GPSM3 bind the GDP bound form of G and prevents the exchange of GDP for GTP, therefore 
affecting downstream signaling (Figure 1)[6]. However, the overarching effect of this interaction 
on cell function is unknown. GPSM3 also contains a motif that binds the G subunit of the 
heterotrimeric G protein[5} and could, therefore, effect downstream signaling of G like the 
phosphorylation of AKT for example. Additionally, GPSM3 has been shown to bind 14-3-3, a 
protein known to regulate cell functions such as signaling, proliferation, apoptosis and metabolic 
Figure 1. Model for GPSM3 function in regulating 
GPCRs. Two of the three GoLoco motifs within 
GPSM3 (yellow) bind to Gαi·GDP subunits. 
Additionally, the LSL motif within GPSM3 interacts 
with Gβ subunits. These interactions regulate ligand-
activated signaling pathways, including Gαi-mediated 
inhibition of cAMP production by adenylyl cyclase, 
inositol phosphate production from Gβγ-mediated 
activation of phospholipase-Cβ, and/or cell survival 
signaling by Gβγ-mediated activation of class IB 
phosphatidylinositol-3’-kinase (PI3K) leading to 
PKB/Akt phosphorylation. GPSM3 also interacts 
directly with 14-3-3 proteins in the cytoplasm and the 
NLRP3 inflammasome.  
pathways[7]. This interaction, which 
stabilizes GPSM3 itself, also keeps 
both proteins exclusively in the 
cytoplasm which impacts the functions 
of both proteins by regulating their 
subcellular localization. Lastly, GPSM3 
has also been shown to interact with 
the C-terminal domain of NOD-like 
receptor family, pyrin domain 
containing 3 (NLRP3), negatively 
regulating the production of IL-1 
through inflammasome activation[8].  
Recent data has shown that two 
single nucleotide polymorphisms 
(SNPs) at the GPSM3 locus are 
associated with a reduced risk of 
developing autoimmunity[9], suggesting 
a potential role for GPSM3 in human autoimmunity. These SNPs have been associated with 
decreased transcript and protein levels of GPSM3 in humans containing the minor allele 
(unpublished data). Furthermore, our lab recently demonstrated that Gpsm3-/- mice are 
protected from both collagen antibody-induced arthritis (CAIA)[10] and collagen-induced arthritis 
(CIA) models (unpublished data). When compared to wild type mice, the Gpsm3-/- mice show 
significantly diminished paw swelling, as well as significant decreases in disease indicators such 
as inflammation, cartilage damage, and periosteum damage as determined by histopathology 
score[10].  
Collectively, these data suggest a potential function of GPSM3 in monocyte or 
macrophage survival and migration to affected areas, but the mechanism is unknown. We first 
hypothesized that GPSM3 regulated monocyte survival signals. In support of this theory, a 
recent study from our group showed that THP-1 monocytes treated with GPSM3-silencing 
shRNA were more sensitive than control cells to apoptosis following etopside treatment[10].  In 
addition, THP-1 cells showed a correlation between decreased levels of GPSM3 and diminished 
phosphorylation of AKT, an intracellular target of the G pathway[6].  AKT phosphorylation is a 
downstream effect of GPCR signaling and has been shown to be part of a pro-survival 
pathway[11]; therefore, if decreased GPSM3 diminishes phosphorylation of AKT in primary 
monocytes as it does in THP-1 cells, this could be a possible mechanism by which GPSM3 
regulates cell survival. Another intracellular pathway of GPCRs that has yet to be studied in this 
context is the pro-survival ERK pathway[12], another potential mechanism for GPSM3 
regulation of cell survival signaling. Additionally, survival of primary monocytes from wild type 
and Gpsm3-/- mice, in response to more physiological stimulations of apoptosis, such as serum 
starvation or TNFα stimulation, has yet to be investigated, nor have the pro-survival effects of 
particular chemokines known to regulate monocyte function been evaluated. These questions 
are the focus of this thesis. 
Here we investigated four chemokines known to regulate monocyte function through G-
protein coupled receptors (Ccl2, Cx3cl1 (fractalkine), chemerin, and Cxcl12), for the ability to 
rescue both wild type and Gpsm3-/- primary monocytes from serum starvation which induces 
Fas-FasL mediated apoptosis[13].  Additionally, we further characterized the different 
populations within our heterogeneous bone marrow derived cell cultures.  Upon this 
characterization, we were driven to also investigate the ability of a single, implicated chemokine 
to rescue the adherent population, which are macrophages[8], from TNFα induced apoptosis, a 
mechanism that does not require cell-cell contact [14] and so is likely a more efficient model for 
non-confluent, adherent cells. In both monocytes and macrophages, phosphorylation of Akt and 
Erk was also compared to investigate potential molecular signaling pathways required for 
Gpsm3 regulation of apoptosis. 
Materials and methods: 
Mice. Experiments were performed using 8-12 week old wild type and Gpsm3 knockout 
(-/-) mice of both C57BL/6 and dba1 strains.  Gpsm3-/- mice were derived as previously 
described.  Parental strains came from the Texas Institute for Genomic Medicine and were 
generated by knocking out a single copy of Gpsm3 using genetrap insertion in embryonic stem 
cells.  The resulting heterozygote mice were crossed to generate homozygous knockouts.[10] 
All work was compliant with IACUC-approved protocols and performed in the AAALAC-
accredited vivarium of UNC. 
Reagents.  Ccl2 (cat# 479-JE), Cx3cl1 (cat# 472-FF), Cxcl12 (cat# 460-SD) and 
chemerin (cat# 2325-CM) chemokines were purchased from R&D Systems (Minneapolis, 
Minnesota).  The flow cytometry antibodies for Ly6C-Brilliant Violet 421 (clone HK1.4), CD11b-
PE (clone M1/70), and CD115-APC (clone AFS98) were purchased from Biolegend (San Diego, 
California), those for Ccr2-PE (clone 475301) and Cx3cr1-PE (goat polyclonal) were purchased 
from R&D Systems, and those for Cxcr4-PE (clone 2b11) and Cmklr1-PE (clone BZ332) were 
purchased from Thermo Fisher Scientific (Waltham, Massachusetts). Antibodies for western 
blotting, including phospho-Akt (ser473) (clone D9E), total Akt (clone C67E7), phospho-Erk 
(thr202/tyr204) (clone D13.14.4E), total Erk (clone 137F5), -Actin (clone 8H10D10) and all 
secondary antibodies were purchased from Cell Signaling (Danvers, Massachusetts).  Gapdh 
antibody (cat # 2275-PC) for western blotting was purchased from Trevigen (Helgerman, 
Connecticut).  
Bone Marrow Derived Monocyte Culture.  Primary monocytes were harvested from bone 
marrow as previously described[15]. Briefly, cells were collected from the bone marrow of a wild 
type and a Gpsm3-/- mouse by flushing, and filtered through a 70-micron filter to remove any 
debris. The cells were treated with red blood cell lysis buffer, washed two times with HBSS and 
counted. They were then resuspended to a concentration of 106 cells/mL in RPMI-1640 media 
with 10% bovine growth serum, 50 M 2-mercaptoethanol, 1% Pen-Strep, 20 mM HEPES, and 
20 ng/mL M-Csf (R&D Systems, Minneapolis, MN), and cultured for five days in low-adhesion 
conditions, either in 50 mL conical tubes or on plates pre-coated with 20 μg/mL poly-HEMA 
(poly-2-hydroxyethylmethacrylate, Sigma-Aldrich cat# P3932) to promote monocyte 
differentiation. 
To obtain the adherent macrophages, cells were initially cultured as described 
above.  On day five, the cells were plated on non-tissue culture-treated plates and allowed to 
adhere for 30 minutes before being used in their intended assay. Bone marrow cells 
differentiated in this manner that are adherent have been determined to be macrophages[8]. To 
remove macrophages from the plates, cells were washed with PBS, followed by a wash with 
Versene (0.6 mM EDTA in PBS) and fully released with Accutase solution (Sigma Aldrich). 
Apoptosis Assay.  To test monocyte apoptosis, suspension cells were aspirated off the 
plates, washed twice with HBSS, and aliquoted into tubes at 0.5x106 cells per tube. Apoptosis 
was induced by serum starving the monocytes overnight, which is known to induce spontaneous 
apoptosis through Fas-FasL mediated interactions[13].  To test the ability of four chemokines to 
rescue the cells from Fas-FasL induced apoptosis, the wild type and Gpsm3-/- samples were 
treated with 0.5 mL serum free media plus 100 ng/mL of either Ccl2, chemerin, Cxcl12, or 
Cx3cl1. The “live” control cells were left in complete media with 20 ng/mL M-Csf and the “dead” 
control cells were in serum free media with no chemokine added.  After 20 hours, the cells were 
washed with HBSS and stained with FITC-Annexin V and propidium iodide per the instructions 
in the TACS Annexin V-FITC Apoptosis Detection Kit (Trevigen). Samples were analyzed using 
flow cytometry on a Cyan Analyzer from the UNC Flow Cytometry Core Facility. Data is 
expressed as percentage of total cells positive for Annexin V, which includes those in both early 
and late stage apoptosis. 
For adherent macrophages, cells were aliquoted directly from the 50 mL conical tube on 
day five of differentiation onto non-tissue culture-treated 6-well plates (Corning Incorporated, 
cat# 351146) and allowed to adhere for 30 minutes.  Any cells remaining in suspension after the 
30 minutes were considered monocytes and removed.  The adherent cells were washed with 
HBSS. Since the Fas-FasL induced apoptosis using serum free media likely requires cell to cell 
contact, it is not as efficient in non-confluent, adherent cells which do not come into contact, 
compared with suspension cells that freely interact.  To induce apoptosis in the adherent 
macrophages, 10 mM TNF (R&D Systems) was added to the serum free media[14]. Cxcl12 
was added to the sample well at 100 ng/mL to test its ability to rescue the macrophages from 
TNF induced apoptosis. After twenty hours, the samples were released with Accutase solution 
and transferred to tubes for Annexin/PI staining and analysis by flow cytometry.  
Phenotyping.  Cells, either suspension or adherent, were washed twice with HBSS, 
aliquoted into flow cytometry tubes, blocked for 15 minutes with rat serum and Fc block (BD 
Biosciences) and stained with 2 L of antibody for Ly6C, CD11b, CD115, Ccr2, Cx3cr1, CxcR4 
and Cmklr1 in 100 L HBSS for 30 minutes.  Samples were washed twice, resuspended in 400 
L of HBSS and analyzed using flow cytometry on a Cyan Analyzer from the UNC Flow 
Cytometry Core Facility. The UNC Flow Cytometry Core Facility is supported in part by P30 
CA016086 Cancer Center Core Support Grant to the UNC Lineberger Comprehensive Cancer 
Center. 
Western Blot Analysis.   After the five days of differentiation, primary suspension 
monocytes were washed, counted, and resuspended to a concentration of 1x106 in 50 L of 
HBSS so that one million cells could be aliquoted into multiple 1.5 mL tubes. The cells were 
then treated with 100 L of a solution containing 100 ng/ml Ccl2 or chemerin chemokine in 
HBSS over the indicated time course. Ice cold lysis buffer (1% (final) Triton-X100 in HBSS) was 
added to halt the reaction at the appropriate time and lyse the cells. Cells were incubated in 
lysis buffer for 25 minutes at 4 degrees Celsius and then centrifuged for 5 minutes at 3000 rpm 
to pellet nuclei.  The protein-containing supernatant was transferred to fresh tubes and a BCA 
Protein Assay Kit (Thermo scientific, cat # 23227) was utilized to normalize the protein 
concentration according to manufacturer’s instructions. Lysates were resolved on precast Any 
kD Mini-PROTEAN TGX Gels (Bio-Rad Laboratories) in running buffer containing 25 mM Tris, 
192 mM glycine, and 0.1% SDS at pH 8.3 (Bio-Rad). The proteins were transferred to 0.45 m 
pore size PVDF membrane (Millipore) using transfer buffer containing 25 mM Tris, 192 mM 
glycine and 20% methanol. Immunoblotting was done for phosphorylated Akt (ser473), total Akt, 
phosphorylated Erk (thr202/tyr204) and total Erk. Blots were blocked with 5% milk in TBS/T (25 
mM Tris, 135 mM NaCl, 2.7 mM KCl, at pH 7.6, plus 0.1% Tween) for two hours at room 
temperature, incubated in primary antibody at a concentration of 1:2000 in TBS/T with 5% milk 
overnight at 4 degrees Celsius, washed three times for 10 minutes in TBS/T, incubated in HRP-
linked secondary antibody at a concentration of 1:5000 in TBS/T with 5% milk for one hour at 
room temperature, and washed two times in TBS/T and once in TBS before imaging.  Cells 
were imaged using Amersham ECL Select Western Blotting Detection Reagent (GE Healthcare) 
on a G-box Gel Documentation System (Syngene, USA). Phospho-blots were stripped for 15 
minutes using Restore PLUS Western Blot Stripping Buffer (Thermoscientific) and re-probed for 
total protein. Blots were stripped again and re-probed (1:10,000) for GAPDH or -Actin as a 
loading control.  
For adherent macrophages, the procedure above was followed with the exception that 
the cells were lysed on the plate by adding lysis buffer directly and lysing for 30 minutes at 4°C 
with shaking.  Lysates were collected into tubes and then spun down and analyzed as detailed 
above.  
Results: 
Preliminary Phenotyping of bone marrow derived monocytes indicate receptor expression 
 Initially, our cultured bone marrow derived monocytes (BMDMs) were analyzed for 
monocyte marker and chemokine receptor expression using flow cytometry (Table 1). Cells 
were stained individually with each antibody so percentages are of total population.  This was 
done to confirm that our cultured cells were monocytes and that they expressed the chemokine  
receptors of interest.  
 
Gpsm3-/- monocytes lack chemokine protection from Fas-FasL induced apoptosis. 
Since previous studies have shown that THP-1 monocytes treated with GPSM3-/- 
silencing shRNA were more sensitive to apoptosis than control cells[10], we hypothesized that 
primary monocytes from a Gpsm3-/- mouse would follow the same trend when compared to 
cells from a wild type mouse.  Furthermore, since cell survival can be regulated by GPCRs, we 
hypothesized that monocytes from Gpsm3-/- mice would have altered survival responses 
through certain pro-survival GPCRs.  We first used serum starvation, which induces apoptosis 
through Fas-FasL interaction, to induce death in wild type and Gpsm3-/- cells. We then added 
treatments with either Ccl2, Cx3cl1, chemerin, or Cxcl12 to test the ability of these chemokines 
to increase cell survival. Overnight incubation in serum-free media induced apoptosis in both 
Table 1. Wild type and Gpsm3-/- Bone Marrow Derived Monocytes (BMDM) phenotype. 
 Ly6C CD11b Ccr2 Cmklr1 Cx3cr1 
Wild type 80.5 71 51 41 9.5 
Gpsm3-/- 79 70 56 30.5 15.5 
Percentage of total wild type and Gpsm3-/- monocytes expressing the indicated markers and 
receptors. Data is shown as the mean of percent positive, n=2. 
wild type and Gpsm3-/- monocytes at 
comparable levels, although slightly less 
in the wild type cells (Figure 2). Ccl2 
did rescue the cells from apoptosis, 
however, it increased the survival of 
both the knock out cells and wild type 
cells equally. In contrast, Cx3cl1, 
chemerin, and Cxcl12 all showed a 
substantial ability to protect wild type 
cells from apoptosis while failing to 
protect Gpsm3-/- cells (Figure 2). This 
suggests that Gpsm3 is necessary for 
survival signaling with Cx3cl1, chemerin 
and Cxcl12, but not necessarily 
signaling with Ccl2.  
Ccl2 activation of Akt and Erk is not altered in primary Gpsm3-/- monocytes.  
The phosphorylation of Akt and Erk are downstream effects of GPCR signaling and, 
therefore, have the potential to be affected by Gpsm3 interaction with G or G subunits. 
Phosphorylated Akt has been shown to be part of a pro-survival pathway[10]. Since Ccl2 
rescued wild type and Gpsm3-/- cells from apoptosis equally, we hypothesized that there would 
be no difference in Akt activation through phosphorylation at serine 473 or in Erk activation 
through phosphorylation at threonine 202 and tyrosine 204. To measure this we stimulated wild 
type and Gpsm3-/- monocytes with 100 ng/ml Ccl2 and then used Western Blotting to measure 
the level of phosphorylated Akt or Erk over six time points. In congruence with the apoptosis 
assay, no difference in phosphorylation of Akt was found with Ccl2 stimulation between wild 
Figure 2. Monocytes can be rescued from Fas-
FasL induced apoptosis by chemokines. 
Percentage of apoptotic monocytes after overnight 
incubation in the specified conditions determined 
by flow cytometry as described in the Methods.  
Live refers cells in complete media with M-Csf and 
dead refers to cells in serum free media alone, 
without any chemokine, Dotted line represents 
mean apoptosis for dead controls. Chm= 
chemerin. n=1. 
type and Gpsm3-/- monocytes when normalized to the GAPDH load control (Figure 3A). 
Additionally, there was not a significant difference in Erk activation; if anything, the Gpsm3-/- 
monocytes had slightly higher levels of phosphorylated Erk (Figure 3B). 
Monocyte stimulation with chemerin results in differential signaling through Erk.   
Since chemerin rescued wild type but not Gpsm3-/- cells from apoptosis, we 
hypothesized that the Gpsm3-/- monocytes would show reduced activation by chemerin of Akt 
through phosphorylation of serine 473 and Erk through phosphorylation of threonine 202 and 
tyrosine 204. To measure this, we performed a time course stimulation with chemerin of wild 
Figure 3. Akt and Erk activation through Ccl2 stimulation is not diminished in Gpsm3-/- 
monocytes. Western blot analysis for Ccl2 activation of Akt through serine 473 
phosphorylation (A) and Erk through phosphorylation of threonine 202 and tyrosine 204 (B) in 
wild type and Gpsm3 -/- monocytes relative to total protein levels.  Gapdh was used as a load 
control in A. 
type and Gpsm3-/- monocytes and then used western blotting to measure the level of 
phosphorylated Akt or Erk over six time points of stimulation. In contrast to our hypothesis 
based on the apoptosis assay where chemerin rescued the wild type cells but not the Gpsm3-/- 
cells, there was also very little difference in phosphorylated Akt levels between wild type and 
Gpsm3-/- cells (Figure 4A). Similar to the Ccl2 activation, Gpsm3-/- cells actually had slightly 
higher levels of phosphorylated Akt over the time course tested (Figure 4A), which opposes our 
hypothesis based on the known correlation between phosphorylation of Akt and cell survival[6, 
16]  Chemerin-treated wild type and Gpsm3-/- cells did, however, show a substantial difference 
in not just the maximum level of phosphorylated Erk, but also the time course over which it was 
phosphorylated. Maximum activation occurred at 15 minutes in the Gpsm3-/- monocytes, but at 
Figure 4. Akt and Erk activation through chemerin stimulation is not diminished in 
Gpsm3-/- monocytes. Western blot analysis for chemerin activation of Akt through Serine 
473 phosphorylation (A) and Erk through phosphorylation of Threonine 202 and Tyrosine 204 
(B) in wild type and Gpsm3 -/- monocytes relative to total protein levels.   
2 minutes in the wild type (Figure 4B). Contrary to our hypothesis based on the pro-survival 
nature of the Erk pathway[12], Erk activation was substantially increased in Gpsm3-/-monocytes 
(Figure 4B). This suggests that the differential regulation of apoptosis by Gpsm3 must be 
downstream from the phosphorylation of either Erk or Akt or through an alternate pathway. 
Cultured BMDMs are heterogeneous. 
 When trying to repeat the apoptosis data from Figure 2, we had varying results where 
sometimes none of the chemokines rescued either wild type or Gpsm3-/- cells.  We also 
observed that some cells were adhering to the plates even though they were coated with poly-2-
hydroxyethylmethacrylate (poly-HEMA) to prevent adherence.  These observations led us to 
hypothesize that the population of cells we were culturing was heterogeneous. To test this, we 
extended our cell phenotyping of M-Csf differentiated BMDMs to determine the expression of 
three common surface markers associated with monocytes, CD11b, Ly6C and CD115, as well 
as to check for expression of chemokine GPCR receptors by flow cytometry.  Summarized in 
Table 2, only 4-6% of the cells were positive for all three monocyte markers, 62-75% were 
double positive for CD11b and Ly6C, and 15-23% were double positive for CD11b and CD115. 
This experiment was repeated in another mouse model and the average for the three 
populations were 8%, 51% and 15.3% respectively for n=3 (data not shown).  
Table 2. Non-adherent Bone Marrow Derived Monocytes (BMDM) are heterogeneous. 
 
Cell % Ccr2 Cmklr1 Cxcr4 Cx3cr1 
CD11b+ Ly6C+ CD115+ 6/4 54 / 64 28 / 40 38 / 48 3 / 6 
CD11b+ Ly6C+ CD115- 62/75 0 / 0 0 / 0 0 / 0 0 / 0 
CD11b+ Ly6C- CD115+ 23/15 81 / 81 60 / 60 74 / 72 6 / 8.5 
Percentage of non-adherent wild type/Gpsm3-/- cells positive for all three monocyte markers, 
CD11b, Ly6C, and CD115, those positive for only CD11b and Ly6C, and those only positive for 
CD11b and CD115. Within these populations, the percentage of cells expressing the receptors 
Ccr2, Cmklr1, Cxcr4, and Cx3cr1 are also listed.  These are the receptors for Ccl2, chemerin, 
Cxcl12, and Cx3cl1 respectively. 
Adherent bone marrow macrophages (BMM) consist of Ly6Chi and Ly6Clow populations. 
The CD11b marker is also found on 
neutrophils, but in combination with Ly6G rather 
than Ly6C, and so we believe the last 
population in Table 2 could represent neutrophil 
contamination. Of the cells determined to be 
monocytes, only the small percentage that were 
positive for CD115 were positive for the 
chemokine GPCRs.  Additionally, the fact that 
up to 65% of the non-adherent cells do not 
express the chemokine receptors could explain 
why there was variability upon repeating the 
apoptosis assays. For this reason, we decided 
to further characterize the adherent population 
in our cell culture that was evident even on the 
low adherence plates. We considered this 
adherent population to be bone marrow macrophages based on the previously described 
methods for obtaining macrophages[8]. To characterize these cells, we stained for Ly6C and the 
chemokine GPCRs. We found two distinct Ly6Chi and Ly6Clow populations. Importantly, contrary 
to the suspension cells, 73.5% of the cells were Ly6C positive and so there was less neutrophil 
contamination in this population (Figure 5). In addition, both the Ly6Chi and Ly6Clow populations 
were also positive for Ccr2, Cxcr4, and Cx3cr1 (Table 3). Since Gpsm3 regulation is 
presumably through its interaction with the G-proteins of GPCRs, the presence of these GPCRs 
is necessary to evaluate the effects on survival of knocking out this protein. Due to the more 
homogeneous nature of the adherent population and the observation that they all express the 
Figure 5. Adherent Bone Marrow Derived 
Monocytes (BMDM) consist of Ly6Chi 
and Ly6Clow populations. Flow cytometry 
data for adherent population of bone 
marrow derived monocytes, or 
macrophages.  Two distinct populations 
were evident, a Ly6Chi and a Ly6Clow 
population. This image is representative of 
four separate runs. Mean for the Ly6Clow 
population was 37.75%, mean for the 
Ly6Chi population was 35.75%, n=4. Mean 
total cells positive for Ly6C is 73.5% 
GPCRs for our chemokines of interest, we concluded that it would be best to use the adherent 
macrophages to examine Gpsm3 function in apoptosis and signaling. 
 
TNF induced apoptosis is rescued by CXCL12 in wild type but not Gpsm3-/- macrophages. 
Ccr2 was the most predominant receptor on the adherent macrophage population 
(Table 3), however, since our initial data indicated that Ccl2 rescued both wild type and Gpsm3-
/- cells equally, we hypothesized another chemokine might have differential effects on cell 
survival. Cxcr4 was the next highest expressed receptor on the macrophages and Cxcl12, the 
ligand for Cxcr4, did differentially impact wild type and Gpsm3-/- monocyte (BMDM) survival, as 
shown by our initial data. We, therefore, hypothesized that Cxcl12 survival signals would 
depend on Gpsm3 regulation. Therefore, we tested the ability of Cxcl12 to impact macrophage 
survival.  TNF was added to serum free media to induce apoptosis in the adherent cells. We 
chose to use this method to cause apoptosis because FasL-induced apoptosis using serum 
starvation requires cell to cell contact which would likely be less effective when the cells are 
adhered to the plate. Overnight incubation in 10 mM TNF in serum free media induced 
apoptosis in both wild type and Gpsm3-/- monocytes at comparable levels; however, while 
Cxcl12 rescued the wild type macrophages to a level between the live and dead control, it did 
not rescue the Gpsm3-/- macrophages at all (Figure 6). 
Table 3. GPCR expressed predominantly on Ly6C- non-adherent BMDM and both 
Ly6Chi and Ly6Clow adherent BMM populations. 
 
Ccr2 Cxcr4 Cx3cr1 
Suspension Ly6C+ 6 26 2 
Suspension Ly6C- 52 21 19 
Adherent Ly6Chi 31 24 15 
Adherent Ly6Clow 67 32 27 
Percentage of cells expressing receptors for adherent, Ly6C high and Ly6C low populations 
compared to receptor expression on the Ly6C positive and Ly6C negative population, n=1. 
 Gpsm3 may impact Cxcl12 signaling to Akt in macrophages. 
 Since Cxcl12 rescued the wild type macrophages but not the Gpsm3-/- macrophages, 
we hypothesized that similar to the results in the THP-1 cells,[6] there would be diminished 
phosphorylation of Akt, a pro-survival mediator, in the Gpsm3-/- macrophages. We also wanted 
to compare Ccl2 stimulation in the macrophages to the monocytes, hypothesizing that there 
would again be no difference in Akt phosphorylation.  First, we stimulated wild type and Gpsm3-
/- macrophages for 4 minutes, previously determined to be the time point of maximum 
stimulation, with either Ccl2 or Cxcl12 and then performed immunoblotting to test the response.  
Ccl2 stimulated a very low level of Akt phosphorylation in both wild type and Gpsm3-/- 
macrophages, but perhaps slightly lower in the wild type (Figure 7A).  Cxcl12 did show a 
significant level of Akt phosphorylation in both cell types, with a slightly higher activation in the 
Gpsm3-/- macrophages when normalized to the Actin control, which appears to go against our 
hypothesis. To more closely examine Cxcl12 signaling in macrophages, we repeated the 
stimulation over a time course to see if there was a difference in phosphorylation of Akt over 
time in response to Cxcl12.  Again, phosphorylation of Akt was actually slightly increased in the 
Gpsm3-/- cells at the 4-minute time point (Figure 7B). This gives further evidence that the 
Figure 6. Cxcl12 rescues wild type 
bone marrow macrophages (BMM) 
from TNF induced apoptosis. 
Percentage of apoptotic macrophages 
after overnight incubation in the 
specified conditions determined by flow 
cytometry as described in the Methods.  
Live refers cells in complete media with 
M-Csf and dead refers to cells in serum 
free media with 10mM TNF, without 
any chemokine, n=1. 
regulation of apoptosis by Gpsm3 is either downstream of Akt phosphorylation or through 
another mechanism altogether, perhaps due to its binding affinity for 14.3.3. 
 
Discussion: 
Previous studies have demonstrated that silencing GPSM3 in THP-1 cells makes them 
more susceptible to apoptotic death following etopside treatment[10].  The current study takes 
Figure 7. Western blot analysis for Cxcl12 and Ccl2 activation of Akt through Serine 473 
phosphorylation in wild type and GPSM3 -/- macrophages relative to total Akt levels. A. 
Phosphorylated Akt levels in adherent macrophages after a 4-minute stimulation with Ccl2 and 
Cxcl12 as shown compared to unstimulated cells. nt stands for no treatment. B. Phosphorylated 
Akt levels in adherent macrophages stimulated for the indicated amount of time.  
this one step further by using primary monocytes, both wild type and Gpsm3-/-, and tests the 
ability of chemokines to rescue the cells from serum starvation which induces Fas-FasL 
mediated apoptosis[13], a more physiologically relevant model of apoptosis than etoposide 
treatment. While Ccl2 appeared to rescue wild type and Gpsm3-/- cells equally from Fas-FasL 
mediated apoptosis, Cx3cl1, Chemerin, and Cxcl12 all appeared to increase survival of wild 
type cells while failing to do so in the Gpsm3-/- cells (Figure 2). This suggests that Gpsm3 is 
required for pro-survival signaling by Cx3cl1, chemerin and Cxcl12, but not Ccl2. Since 
monocytes play a large role in autoimmune disease, their exhibiting increased apoptosis when 
lacking Gpsm3 could limit the number of cells available to contribute to pathogenesis. This could 
be a substantial contributor to the disease protection that Gpsm3-/- mice experience in 
rheumatoid arthritis models[10], which has also been predicted by SNP analysis in humans[9].  
To investigate possible pathways for the role of Gpsm3 in survival, phosphorylated Akt 
and Erk levels in response to Ccl2 and chemerin stimulation were measured over a time course 
in both wild type and Gpsm3-/- BMDMs.  Both Akt and Erk are intracellular signal transduction 
proteins that have been associated with cell survival, particularly in cancer cells which are 
resistant to apoptosis[11, 12]. Since Gpsm3 possesses a motif that binds the G subunit of 
GPCRs[16], and Gγ is an upstream regulator of these pathways, a downstream effect on Akt 
or Erk phosphorylation is a possible mechanism for the role of Gpsm3 in cell survival. Ccl2 
treatment resulted in no significant difference in Akt or Erk phosphorylation between wild type 
and Gpsm3-/- monocytes, which corresponded to its similar effect on apoptosis in wild type and 
Gpsm3-/- monocytes (Figure 3).  In contrast, chemerin effected both Akt and Erk 
phosphorylation in Gpsm3-/- monocytes slightly more than in wild type cells; the increase was 
slight in phospho-Akt and was more distinct for phospho-Erk (Figure 4). These results indicate 
that Gpsm3 binding to G may actually be inhibitory such that its removal slightly increases the 
downstream effects of the G pathway, such as phosphorylation of Akt. Gpsm3 also appears to 
have a role in Erk signaling; however, the regulatory mechanism and downstream functional 
impact is still not clear. The conflict between reduced survival in Gpsm3-/- monocytes but 
increased phosphorylation of Akt and Erk, documented to be pro-survival, suggests that Gpsm3 
is regulating apoptosis through an alternative mechanism, which does not involve classical Akt 
or Erk pathways, or may function independently. Interestingly, total Akt was reduced in the 
samples where Akt was phosphorylated even though the loading controls were even (Figures 3 
and 7). Although less pronounced, this is slightly evident in the Erk blots as well. One possible 
explanation for this is that the phospho-protein antibody is not being completely stripped and so 
is interfering with the binding of the total protein antibody. This has been noted by other 
investigators in our department. Furthermore, following phosphorylation of serine 473, Akt has 
been shown to be poly-ubiquitinated and marked for proteasome degradation[17],  which could 
impact total Akt levels following chemokine stimulation. Another potential explanation is that 
these proteins are being phosphorylated and then shuttled to the nucleus[18-21]; since we lyse 
with 1% Triton-X100, the nuclear envelope is not being lysed and so nuclear proteins are not 
included on the blot. To test the theory of antibody interference, the total Akt blot in Figure 7B 
was done prior to phospho-Akt immunoblotting.  The stimulated lanes are still slightly reduced in 
the wild type, which supports the theory that the protein may be shuttled to the nucleus after 
phosphorylation. Future directions include using a stronger lysis buffer (e.g., RIPA) to 
completely solubilize both the cell membrane and nuclear membrane. 
 Varying results upon trying to repeat the apoptosis data drove us to look more closely at 
our cultured suspension cell population. As a result, we have characterized, and thus made 
important distinctions between, the heterogeneous suspension cell population and the more 
homogeneous adherent cell populations. We concluded that the adherent macrophage 
population appears to be more compelling for the purposes of this study. The suspension 
population was found to contain a large amount (15-23%) of contaminating neutrophils, which 
did express the relevant chemokine GPCRs, while only a very small proportion (4-6%) of 
monocytes expressed these receptors (Table 2). The majority (62-75%) of these cultured 
BMDM cells were monocytes that did not express these GPCRs at all. Therefore, any 
differential survival in this cell population had to be a result of the smaller population of cells, 
including neutrophils, which could explain the varying results when using a heterogeneous cell 
population. The adherent cells proved to be a much more homogeneous population with reliable 
receptor expression. Almost all of these cells (73.5%) are Ly6C positive (Figure 5) and a 
significant portion of both the Ly6Chi and Ly6Clow populations express the relevant chemokine 
receptors (Table 3). Macrophages, which develop from monocytes, are also critical mediators of 
inflammation. For this reason, we decided to turn our focus to these macrophages. 
 Since serum starvation induces Fas-FasL mediated apoptosis, which requires cell to cell 
contact [13] and so is likely less efficient in cultured adherent cells that are non-confluent and 
may not come into direct contact, we used TNF to induce apoptosis in the adherent 
macrophages. TNF is the natural ligand for cell surface receptors, TNFR1 and TNFR2, 
which trigger cell death[14].  We tested the ability of Cxcl12 chemokine to differentially increase 
survival of wild type versus Gpsm3-/- macrophages because it had shown promise in the 
monocyte trial (Figure 2) and its receptor, Cxcr4, was the second most expressed receptor on 
these cells (Table 3). The most abundant GPCR, Ccr2, the receptor for Ccl2, had shown no 
dependence on Gpsm3 in the monocytes and thus was used initially as a control. As shown in 
Figure 6, Treatment with TNF did induce apoptosis in both wild type and Gpsm3-/- 
macrophages; however, while Cxcl12 rescued wild type cells to a level between the live and 
dead controls, it did not show any rescue in the Gpsm3-/- cells. This suggests that Gpsm3 
regulation continues after monocytes differentiate into macrophages. If both Gpsm3-/- 
monocytes and macrophages exhibit increased cell death in vivo as they have shown ex vivo, 
this provides further evidence that the reduction in disease pathogenesis could be attributed to 
dysregulated survival of the Gpsm3-/- immune cells. 
 Akt activation was investigated by a four-minute stimulation with both Ccl2 and Cxcl12. 
While the response was quite low from Ccl2, it was substantial from Cxcl12 with noticeably 
increased levels of phosphorylated Akt in the Gpsm3-/- cells when normalized to Actin control 
(Figure 7A). Furthermore, the time course stimulation with Cxcl12, also showed increased 
levels of Akt phosphorylation (Figure 7B). This further supports the theory that Gpsm3 could 
have an inhibitory effect on Akt phosphorylation and so regulation of cell survival by Gpsm3 
might act through an alternative mechanism.  For example, 14-3-3 is a downstream substrate of 
Akt that also has been shown to bind directly to Gpsm3 (Figure 1)[7, 22].  14-3-3 proteins also 
have a role in regulating cell cycle and apoptosis [23, 24] and could be functionally important in 
macrophage inflammation, but investigation into this potential pathway was beyond the scope of 
this study.   
 In summary, our apoptosis data does support the hypothesis that Gpsm3-/- monocytes 
and macrophages show dysregulated GPCR survival responses, but the mechanism requires 
further investigation.  It does not appear that activation of Akt or Erk is diminished, but rather is 
increased in the Gpsm3-/- cells, which implies that this is likely not the pathway through which 
Gpsm3 directly regulates cell survival.  Future directions include repeating the apoptosis data in 
the macrophages to obtain significance.  Additionally, other pathways should be explored in 
attempt to work out the mechanism through which Gpsm3 regulates cell survival, perhaps 
further investigating the interactions between Gpsm3 and 14-3-3 or NLRP3, and by testing other 
known signal mediators, such as caspase-3.[20]  Finally, the Gpsm3-/- mice do not appear to 
have reduced lifespans; however, they have not been immunologically challenged. Given the 
role of macrophages in innate immunity, it would be worthwhile to investigate whether these 
mice have any deficits in the immune response to infectious disease.  This would be an 
important piece of information before looking into this protein as a potential drug target.   
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